acquired

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

Source Node:
Time Stamp: January 29, 2024 6:55 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

Source Node:
Time Stamp: August 17, 2023 3:06 PM - Modified On: August 17, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Source Node:
Time Stamp: November 13, 2022 3:46 AM - Modified On: November 17, 2022 - Published By:
Source Cluster:
Republished By Plato

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that

Wikisoft Corp – Pioneering Startup Funding with Blockchain Acquisition

Source Node:
Time Stamp: March 8, 2022 8:56 AM - Modified On: March 8, 2022 - Published By:
Source Cluster:
Republished By Plato

San Francisco, March 8, 2022 - Wikisoft Corp. (the “Company,” “we,” and “our”) (OTCQB: WSFT) recently announced that it has acquired 51% of Etheralabs LLC a New York City based venture lab and ecosystem that invests in, builds, and deploys disruptive technologies across the Blockchain space. Wikisoft´s vision is to combine the company’s massive amount of data on start-ups, funds and investors with Etheralabs’ disruptive Blockchain technology to accelerate finance partnerships between startups and investors - Wikisoft providing the relevant data intelligence and direct investment opportunities and Etheralabs providing the Blockchain expertise and

Fastbase (OTC:FBSE) Acquires Strategic Stake in New York-Based Blockchain Technology Company Etheralabs.io

Source Node:
Time Stamp: March 3, 2022 10:09 AM - Modified On: March 7, 2022 - Published By:
Source Cluster:
Republished By Plato

New York, March 3, 2022 Fastbase. ("The Company", "we" and "our") (OTC: FBSE) announced today that it has acquired 24.5% of Etheralabs LLC, a New York City based venture lab and ecosystem that invests in, builds and implements disruptive technologies across the Blockchain area. Fastbase CEO Rasmus Refer said: "Etheralabs LLC's disruptive technology and products are in line with Fastbase's mission to become the world's leading data provider. Fastbase's vision is always to be first with the most superior technologies to collect, analyze and provide data to companies to empower